NeuroLynQ uses GSR to assess an audience’s nonconscious emotional response; this new release includes additional analytical capabilities   CAMBRIDGE, MA – Apr. 18, 2019 – Shimmer, a global leader in wearable technology for research applications, today announced the launch of … Read More »

Quote from Lonza Group CEO Marc Funk: “Q1 results demonstrate that Lonza today has two segments operating in different markets and growing at varying paces; so their performance and challenges should not be compared. “Our Pharma Biotech & Nutrition business continued to … Read More »

Ulsan University Hospital (UHH) and Seoul National University Hospital (SNUH), Hepatology Division join Novotech’s CRO partnership program SYDNEY, Apr 18, 2019 – (ACN Newswire) – Novotech, the award-winning Asia-Pacific CRO with 23 years of experience in the region, has furt … Read More »

April 18, 2019 (Las Vegas, NV) – The International Society for CNS Drug Development (ISCDD),  a non-profit, independent society focused on improving CNS drug development,  announced today that Sharon Mates, Ph.D., Co- Founder, Chairman, and Chief Executive Officer, of Intra- … Read More »

NIH scientists and funding contributed to development of experimental treatment A small clinical trial has shown that gene therapy can safely correct the immune systems of infants newly diagnosed with a rare, life-threatening inherited disorder in which infection-fighting im … Read More »

New executives will contribute scientific, operational and consulting expertise to support Simcyp’s growing footprint in drug development and regulatory decision-making Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence an … Read More »

PureTech Health to receive up to $26 million in upfront payments, research support, and preclinical milestones and is eligible to potentially receive more than $200 million in milestones, in addition to royalties Collaboration will initially focus on developing Boehringer In … Read More »

Encube Ethicals, an integrated pharmaceutical organisation specialising in topical, transdermal and complex delivery solutions, has announced that its new high potency manufacturing facility for topical formulations is now fully operational. The new 205 sq. m. facility, at i … Read More »

Morrisville, NC – (April 17, 2019) – Circassia Pharmaceuticals Inc. (“Circassia” or “the Company”), today announced that the US Food and Drug Administration has approved DUAKLIR® PRESSAIR® (aclidinium bromide and formoterol fumarate) for the maintenance treatment of patients … Read More »

By Andrea Park IBM has discontinued the development and sales of its Watson for Drug Discovery product due to poor financial performance, according to STAT. This usage of IBM’s Watson artificial intelligence software was introduced in 2014, with the aim of assisting pharmace … Read More »

Dotmatics, a leading provider of scientific informatics solutions and services, today announced a new release of its informatics suite, Dotmatics 5.4; designed to handle very large data assays, with enhanced Browser search and featuring a newly refined Notebook interface. Fo … Read More »

by Angus Liu Amgen is pricing its newly approved osteoporosis drug Evenity on par with Radius Health’s competitor anabolic Tymlos. But its cardiovascular risk has already drawn outcry from a consumer activist group, and at least one analyst isn’t so enthusiastic about its bl … Read More »

Companies will leverage extensive knowledge in conversational AI to solve customer experience challenges for health care PHILADELPHIA – OZ, a global consulting company enhancing customer experiences through digital innovation, has announced its partnership with Orbita, Inc., … Read More »

By James Paton After more than three decades of work and almost $1 billion of investment, GlaxoSmithKline Plc and its partners are ready to deploy a vaccine for malaria, the mosquito-borne disease that kills almost half a million people each year. The vaccine, developed with … Read More »

16th April 2019: New data from CPhI shows that, despite ongoing reputational challenges, India’s biologics market is set for robust growth in 2019 driven by biosimilars production. The India specific findings from CPhI’s bio league tables predict strong ‘bio growth potential … Read More »

Authors, publishers and medical affairs teams continue turning to QxMD to convert decision support tools into interactive online and app-based tools with built-in audience reach. VANCOUVER, Canada, April 15, 2019 – QxMD Software Inc., a digital learning technology company th … Read More »

By Maggie Lynch Boehringer acquires rights to ICD Therapeutics and its biologics-delivery platform for the development of oncology and immune oncology compounds. Using the acquired platform, Boehringer Ingelheim will work with nanoPET Pharma GmbH, a former shareholder of ICD … Read More »

Notable, which is redefining cancer treatment with a clinically validated AI platform that rapidly advances cancer drug development at a fraction of traditional costs, and Stanford Medical Center announced today the results of a new study on the feasibility of personalized m … Read More »

Sharp – part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has received approval from the Medicines and Healthcare Product Regulatory Agency (MHRA) to begin production at its Clinical Services Centre of Excellence in Rhymney, Wale … Read More »

Company focuses on energizing and empowering investigative sites that support clinical research The WIRB-Copernicus Group® (WCG™) is pleased to announce the addition of several prominent executives to its Site Division and the expansion of its Global Research Network … Read More »